Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
kanggeon.kim@ndcls.ox.ac.uk

Kanggeon Kim

Postdoctoral Researcher in Gene Regulation

Recent publications

Silencing of SOD1 sensitises ATRX-deficient cells to camptothecin treatment through increased activity of the alternative lengthening of telomeres pathway.

Mattis N. et al, (2025), Hum Mol Genet, 34, 1638 - 1647

Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway.

Kang E. et al, (2022), Cancer Gene Ther, 29, 1168 - 1180

Correction to: Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway.

Kang E. et al, (2022), Cancer Gene Ther, 29

More publications